Research
Hormonal
Advanced pharmacotherapy with GLP-1 receptor agonists can achieve 15%–20% weight loss.
Clinicians can consider GLP-1 receptor agonists as an effective pharmacotherapy option for weight loss.
StrongSupportsmedium confidence
Treatment modalities range from behavioral interventions to advanced pharmacotherapy with glucagon-like peptide-1 (GLP-1) receptor agonists, achieving 15%–20% weight loss.
Why this rating
The claim is based on a narrative review synthesizing evidence from various sources.
Source
Comprehensive Obesity Management in Clinical Practice: From Diagnostic Assessment to Evidence-Based Treatment Strategies
Vignesh Gunasekaran et al. · European Journal of Medical and Health Sciences · 2025
review
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →